How CBD Teatment For Covid 19 Infection Is Proven With Studies ?


Its 2021 and lockdown restrictions may be easing around the globe, but COVID-19 still remains a
real threat. We are still witnessing alarming outbreaks of the novel coronavirus but an alternative treatment could be studies away. CBD could play a role in the treatment of covid 19 as a potential full distribution of vaccines is still months away.


covid vaccine cbd


Can CBD Be Used To Treat Covid 19 Infection ?

The latest research indicates that help may come from an unexpected direction: cannabidiol, also known as CBD.

The hunt for drugs that may treat COVID-19 and the associated symptoms have led researchers to both traditional and less traditional courses. Drug research looked into existing options such as remdesivir, chloroquine, favipiravir, and other antivirals. But in most cases, little to no efficacy was shown against COVID-19.

Cannabis offers a number of active compounds that make it a prospective and potential adjunct treatment for coronavirus infection.


live labs independent


So can cannabis treat covid 19? Researchers are exploring the potential of CBD in reducing the susceptibility to the infection.

Also, the possibility of using it as an antiviral medication is being evaluated.

The role of CBD in COVID-19 is attracting attention. Recently, researchers from the Texas
Biomedical Research Institute and the University of Nebraska recommended more extensive
research to look into how CBD might help treat this deadly infection from coronavirus. They
highlighted the evidence on how cannabis-specific anti-inflammatory properties can help.


covid inflammation treated cbd


Studies Shows CBD As Promising Treatment For Coronavirus

Scientists suggest that acute infection is associated with a cytokine storm. It contributes to
symptoms such as cough, fever, and muscle pain during covid. Cytokines are molecules responsible for
signaling inflammation. They are often released by our body in response to infections. They activate
inflammatory processes in order to contain and eradicate the pathogen. In a cytokine storm,
the host’s immune system ends up releasing too many molecules of cytokines, which result in
more collateral damage than the virus itself would’ve caused.

The extreme cases of inflammation can cause severe pneumonia, which may eventually end
up clogging the lungs. This makes breathing more difficult or even impossible in some

Hence, one of the most important strategies medical researchers are working on, in
the fight against COVID-19, is to limit or minimize the inflammatory response.
CBD for covid treatment has demonstrated some serious anti-inflammatory properties in studies.

It also doesn’t produce disorienting psychotropic effects associated with a chemical compound
known as THC.

Moreover, it’s already approved by the FDA as safe for young kids with
intractable epilepsy. So, if it proves successful in reducing inflammation for COVID-19
patients, it will be a lot safer alternative to manage inflammation than other options.



CBD Has Proven To Reduce Inflammation

Research shows that CBD has the ability to reduce ACE2 expression and pro-inflammatory
cytokine production to deal with lung inflammation. The study proposed that some strains
of cannabis might help to reduce the coronavirus’ ability to enter our lungs, which is the spot
where this virus takes hold, reproduces, and spreads further.

The SARS-CoV-2 typically needs a receptor to enter the host. The humans have that receptor,

which is known as orangiotensin-converting enzyme II (or ACE2). This enzyme (and potential

receptor forCOVID-19) is normally found in our lung tissue, kidneys, nasal or oral mucosa, and
gastrointestinal tract. The virus uses this enzyme to infect cells in the nearby tissues. Hence,
by downregulating the synthesis of ACE2, CBD treatment for coronavirus is promising.

But only very few studies have tested these theories with actual experiments and
investigations. New evidence keeps adding support to the potential of CBD treatment against COVID19.


covid 19 treatment


CBD Treatment In Respiratory Distress

A study at Augusta University suggested that CBD may positively impact acute
respiratory distress syndrome (ARDS), which is a very dangerous symptom of COVID-19
caused by a hyperactive inflammatory response. Currently, there is no definitive cure or
treatment for ARDS other than supportive measures. There is a dire need for effective
therapeutic modalities to combat ARDS in order to improve the prognosis of COVID-19 in
severely ill patients.


live labs independent


This is where CBD has some potential and may help to overcome the
current hurdles in treating COVID-19 cases. Studies also suggest that CBD plays a role in
lowering the concentration of specific cytokines such as interleukin IL-17, IL-1b, and IL-6.
This may help in bringing down the inflammation and eventually end the respiratory distress.

A previous animal study on asthma suggested that CBD treatment is able to diminish airway
inflammation and lower the production of pro-inflammatory cytokines. The same study
also highlighted CBD’s effect on reducing pulmonary fibrosis – a medical condition in which
your lungs become damaged and scarred. The lung tissue gets thickened, making breathing
extremely difficult. This finding was highly relevant, as COVID-19 can also leave some
patients with severe pulmonary fibrosis.



CBD And NSAIDS To Treat Covid Symptoms

If CBD is successful in mitigating exaggerated inflammation effects, we can expect to
observe a significant improvement in the condition of COVID-19 patients with CBD.
Clinicians could possibly use cannabinoids as a part of the treatment regime, with
nonsteroidal anti-inflammatory drugs (NSAIDs) along with other medications to
downregulate the cytokine superstorm.

Studies suggest that CBD is a potentially reasonable candidate to be
studied in the preclinical coronavirus models. But we are far from the level of evidence
required to consider using cannabinoids as pharmacotherapy for COVID-19.

We need evidence-based approaches backed by extensive research and human trials to validate CBD’s
use as a therapeutic strategy in the face of the current coronavirus pandemic.

At this point in time, it’s ‘all hands on deck’ for every facet of science to defend humankind
during this pandemic. The need for an effective treatment for COVID-19 is urgent. If life is to
go on safely, and the world economy is to survive this crucial time, people may be willing to
adopt cannabis treatment for covid.




1. Quinn, M. (2020). Fauci warns U.S. “unlikely” to reach herd immunity if too many refuse vaccine. CBC
NEWS. Retrieved from:
2. Wang, B.; Kovalchuk, A.; Li, D.; Ilnytskyy, Y.; Kovalchuk, I.; Kovalchuk, O. In Search of Preventative
Strategies: Novel Anti-Inflammatory High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in
COVID-19 Gateway Tissues. Preprints 2020, 2020040315 (doi: 10.20944/preprints202004.0315.v1).
3. Hill KP (2020) Cannabinoids and the coronavirus, Cannabis and Cannabinoid Research 5:2, 118–120, DOI:
4. Byrareddy, S. N., & Mohan, M. (2020). SARS-CoV2 induced respiratory distress: Can cannabinoids be
added to anti-viral therapies to reduce lung inflammation?. Brain, behavior, and immunity, 87, 120–121.
5. Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009). Cannabinoids as novel antiinflammatory drugs. Future medicinal chemistry, 1(7), 1333–1349.
6. CS Chem. Neurosci. 2014, 5, 11, 1131–1141 Publication Date:July 16, 2014
7. Wang, B.; Kovalchuk, A.; Li, D.; Ilnytskyy, Y.; Kovalchuk, I.; Kovalchuk, O. In Search of Preventative
Strategies: Novel Anti-Inflammatory High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in
COVID-19 Gateway Tissues. Preprints 2020, 2020040315 (doi: 10.20944/preprints202004.0315.v1).
8. Vuolo, F., Abreu, SC., Michels, M. (2018). Cannabidiol reduces airway inflammation and fibrosis in
experimental allergic asthma. European Journal of Pharmacology.
9. George, PM., Wells, AU. Jenkins, RG. (2020). Pulmonary fibrosis and COVID-19: the potential role for
antifibrotic therapy. The Lancet Respiratory Medicine. DOI:
10. D’Elia RV, Harrison K, Oyston PC, et al. Targeting the “Cytokine Storm” for therapeutic benefit. Clin Vaccine
Immunol. 2013;20:319–327. Crossref, Medline, Google Scholar
11. Reiss CS. Cannabinoids and viral infections. Pharmaceuticals. 2010;3:1873–1886. Crossref, Google Scholar
12. Tahamtan A, Tavakoli-Yaraki M, Rygiel TP, et al. Effects of cannabinoids and their receptors on viral
infections. J Med Virol. 2016;88:1–12. Crossref, Medline, Google Scholar